Functionalization with a VEGFR2‐binding antibody fragment leads to enhanced endothelialization of a cardiovascular stent in vitro and in vivo

• Published in: Journal of biomedical materials research. Part B, Applied biomaterials Vol. 108; no. 1; pp. 213 - 224
• Main Authors: Wawrzyńska, Magdalena, Kraskiewicz, Honorata, Paprocka, Maria, Krawczenko, Agnieszka, Bielawska‐Pohl, Aleksandra, Biały, Dariusz, Roleder, Tomasz, Wojakowski, Wojciech, O'Connor, Iain B., Duda, Maciej, Michal, Robert, Wasyluk, Łukasz, Plesch, Gustav, Podbielska, Halina, Kopaczyńska, Marta, Wall, J. Gerard
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.01.2020; Wiley Subscription Services, Inc
• Subjects: Antibodies; antibody fragment; Arteries; Biocompatibility; Biomedical materials; cardiovascular stent; Cardiovascular system; Coating; Coatings; Coronary artery; Cytotoxicity; Disks; E coli; Endothelial cells; endothelialization; Endothelium; Erythrocytes; Fragments; Growth factors; Histology; Implants; In vivo methods and tests; Materials research; Materials science; Progenitor cells; Restenosis; Stainless steel; Stainless steels; Stem cells; Stents; Surgical implants; Thickness; Toxicity; Umbilical vein; Vascular endothelial growth factor; VEGFR2; VEGFR2; cardiovascular stent; endothelialization; antibody fragment
• ISSN: 1552-4973; 1552-4981
• DOI: 10.1002/jbm.b.34380

Rapid endothelialization of cardiovascular stents is critical to prevent major clinical complications such as restenosis. Reconstruction of the native endothelium on the stent surface can be achieved by the capture of endothelial progenitor cells (EPCs) or neighboring endothelial cells (ECs) in vivo. In this study, stainless steel cardiovascular stents were functionalized with recombinant scFv antibody fragments specific for vascular endothelial growth factor receptor‐2 (VEGFR2) that is expressed on EPCs and ECs. Anti‐VEGFR2 scFvs were expressed in glycosylated form in Escherichia coli and covalently attached to amine‐functionalized, titania‐coated steel disks and stents. ScFv‐coated surfaces exhibited no detectable cytotoxicity to human ECs or erythrocytes in vitro and bound 15 times more VEGFR2‐positive human umbilical vein ECs than controls after as little as 3 min. Porcine coronary arteries were successfully stented with scFv‐coated stents with no adverse clinical events after 30 days. Endovascular imaging and histology revealed coverage of the anti‐VEGFR2 scFv‐coated stent with a cell layer after 5 days and the presence of a neointima layer with a minimum thickness of 80 μm after 30 days. Biofunctionalization of cardiovascular stents with endothelial cell‐capturing antibody fragments in this manner offers promise in accelerating stent endothelialization in vivo. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 108B:213–224, 2020.